Lucis
Builds a preventive health platform, backed by Y Combinator and financed by a €17.3 million Series A led by Singular.
Overview
Lucis is a French preventive health platform categorized in AI healthcare. The round context does not disclose specific product features, clinical workflows or customer segments, but positions the company in the preventive health market. The company is backed by Y Combinator and raised a €17.3 million Series A led by Singular, equivalent to about $20 million in total funding across one disclosed round. Its key disclosed differentiators are its preventive health focus, French base and YC affiliation.
Funding History
YC-backed French preventive health platform Lucis raises €17.3 million Series A led by Singular
Frequently Asked Questions
- How much funding does AI Funding track for Lucis?
- AI Funding tracks $20M for Lucis across 1 funding round in this database.
- Who are Lucis's investors?
- Lucis's investors include Singular.
- What does Lucis do?
- Lucis is a French preventive health platform categorized in AI healthcare. The round context does not disclose specific product features, clinical workflows or customer segments, but positions the company in the preventive health market. The company is backed by Y Combinator and raised a €17.3 million Series A led by Singular, equivalent to about $20 million in total funding across one disclosed round. Its key disclosed differentiators are its preventive health focus, French base and YC affiliation.
- Where is Lucis headquartered?
- Lucis is headquartered in France.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.